Literature DB >> 31113723

Frailty assessment in older adults undergoing interventions for peripheral arterial disease.

Laura M Drudi1, Matthew Ades2, Rita Mancini3, Catherine Boudrias3, Daniel I Obrand4, Oren K Steinmetz4, Jonathan Afilalo5.   

Abstract

OBJECTIVE: Frailty is a multidimensional syndrome that influences postoperative morbidity and mortality after vascular procedures; however, its integration in clinical practice has been limited, given the lack of consensus on how to measure it. This study sought to compare the incremental predictive value of six different nonphysical performance frailty scales to predict poor outcomes after interventions for peripheral arterial disease (PAD).
METHODS: This preplanned analysis of the FRailty Assessment In Lower Extremity arterial Disease (FRAILED) prospective cohort included two centers recruiting patients between July 1, 2015, and October 1, 2016. Individuals who underwent vascular interventions for Rutherford class 3 or higher PAD were enrolled. The following scales were compared: Edmonton Frail Scale, Groningen Frailty Indicator (GFI), modified Essential Frailty Toolset (mEFT), modified Frailty Index, Multidimensional Prognostic Index, and the Risk Analysis Index-C. The primary end point was a composite of all-cause mortality and major disability at 12 months after the procedure. The secondary end point was length of stay. Logistic regression was used to determine the association of frailty with the primary end point after adjusting for confounders. To compare the incremental predictive value of each frailty scale, model performance statistics were calculated.
RESULTS: The cohort was composed of 148 patients with a mean age of 70 years. Depending on the scale used, the prevalence of frailty ranged from 16% to 70%. Frailty as measured by the GFI (adjusted odds ratio, 1.76; 95% confidence interval, 1.14-2.72) and mEFT (adjusted odds ratio, 2.71; 95% confidence interval, 1.29-5.73) predicted mortality and worsening disability at 12 months after interventions for PAD. Furthermore, there was statistically significant C-statistic, Bayesian information criterion, and integrated discrimination improvement when the GFI and mEFT were added to the baseline model. Frailty was not associated with length of stay.
CONCLUSIONS: Frailty is associated with mortality and worsening disability after interventions for PAD. The GFI and mEFT performed well and identified vulnerable older adults who are at risk of poor outcomes after interventions for PAD and recommended for use in this setting.
Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Frailty; Peripheral arterial disease; Risk prediction

Mesh:

Year:  2019        PMID: 31113723     DOI: 10.1016/j.jvs.2018.12.052

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

Review 1.  A multidimensional approach to frailty in older people.

Authors:  Alberto Pilotto; Carlo Custodero; Stefania Maggi; Maria Cristina Polidori; Nicola Veronese; Luigi Ferrucci
Journal:  Ageing Res Rev       Date:  2020-03-21       Impact factor: 10.895

2.  Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort.

Authors:  Jung-Joon Cha; Hyoeun Kim; Young-Guk Ko; Donghoon Choi; Jae-Hwan Lee; Chang-Hwan Yoon; In-Ho Chae; Cheol Woong Yu; Seung Whan Lee; Sang-Rok Lee; Seung Hyuk Choi; Yoon Seok Koh; Pil-Ki Min
Journal:  Cardiovasc Diabetol       Date:  2020-06-22       Impact factor: 9.951

Review 3.  Frailty assessment in older urological patients prior to surgery: a systematic review and narrative synthesis.

Authors:  Andrea Haren; Rajni Lal; David Walker; Rajesh Nair; Judith Partridge; Jugdeep Dhesi
Journal:  Ther Adv Urol       Date:  2020-05-10

4.  The Impact of Chronic Kidney Disease on Mid-Term Outcomes after Revascularisation of Peripheral Arterial Occlusive Disease: Results from a Prospective Cohort Study.

Authors:  Artur Kotov; Deven A Blasche; Frederik Peters; Philip Pospiech; Ulrich Rother; Konstantinos Stavroulakis; Jürgen Remig; Christian Schmidt-Lauber; Thomas Zeller; Hartmut Görtz; Jörg Teßarek; Christian-Alexander Behrendt
Journal:  J Clin Med       Date:  2022-08-14       Impact factor: 4.964

5.  Transitions in frailty state after kidney transplantation.

Authors:  Evelien E Quint; Lasse Schopmeyer; Louise B D Banning; Cyril Moers; Mostafa El Moumni; Gertrude J Nieuwenhuijs-Moeke; Stefan P Berger; Stephan J L Bakker; Robert A Pol
Journal:  Langenbecks Arch Surg       Date:  2020-07-20       Impact factor: 3.445

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.